ARTICLES BY THIS AUTHOR
- 2/4/2024
As investors pile into psychedelics, idealism gives way to pharma economics
While psychedelics are still illegal under U.S. federal law, companies are jostling to try and patent key ingredients found in magic mushrooms, ayahuasca and other substances. - 2/4/2024
COVID-19 reinfection rates high among people who are homeless, Toronto study says
The researchers followed 381 homeless people who had previously been infected with COVID-19 for about a year. - 2/4/2024
Company behind lab-grown milk protein eyes Canadian animal-free dairy market
Health Canada also says this protein ‘is no different in nutritional value compared to whey protein from cow’s milk.’ - 2/4/2024
Case report: On awakening
Dr. Robert Dickson comes across a case that reminds us of a lot of the important aspects of medical care. - 2/1/2024
Lupus and other autoimmune diseases strike far more women than men. Now there’s a clue why
It’s all about how the body handles females’ extra X chromosome. - 2/1/2024
Popularly known as ‘gas station heroin,’ tianeptine is being sold as a dietary supplement—with deadly outcomes
Tianeptine stimulates the same receptors as well-known opioids such as fentanyl, heroin and morphine. - 2/1/2024
Physicians as pharmacy owners
Laying back on his couch at the end of a long day, Dr. Jabir Jassam thought up a potentially lucrative venture. - 2/1/2024
It’s called ‘cozy cardio.’ In a world seeking comfort, some see a happier mode of exercise
No stress, no membership fees, no preening for other, buffer-than-thou gym rats. And you can even have a cup of hot tea by your side. - 2/1/2024
Alberta premier’s policy changes around trans youth could be harmful: doctors
‘Firstly, she doesn’t have the medical expertise to be able to make that decision about whether gender-affirming care is appropriate. Secondly, calling some of these things irreversible or harmful is simply false.’ - 2/1/2024
Health officer advises B.C. to offer smokable fentanyl in report backing safer supply
Dr. Bonnie Henry says there is concern among clinicians over drugs being diverted from safe supply programs—but not much that can be concretely said on how bad the problem is.